| Primary information |
|---|
| PRRID | PRRID_1380 |
| Ligand Name | IMO-2055 |
| Source | NA |
| Sequence of ligand | NA |
| Length | NA |
| Type | Nucleic Acid |
| Occurence | Synthetic |
| Role of Ligand | it enhances the efficacy of antitumor agents through immune stimulation |
| Name of receptor | Toll-like receptor 9 (TLR9) |
| Type of receptor | Toll-like receptor (TLR) |
| Source | Human patients with advanced non-small cell lung cancer (nSClC) |
| Localization | monocyte/macrophages, plasmacytoid DCs and B-lymphocytes |
| Domain | cell compartment |
| Sequence of Receptor | Q9NR96.fasta |
| Swiss prot ID | Q9NR96 |
| Length Of Receptor | 1032 |
| Function | TLR9 plays a crucial role in breaking tolerance and developing autoimmunity |
| Assay used | NA |
| PMID | 24770667 |
| Year of Publication | 2014 |
| Pubchem assay | Pubchem_assay |
| Primary information |
|---|
| PRRID | PRRID_1380 |
| Ligand Name | IMO-2055 |
| Source | NA |
| Sequence of ligand | NA |
| Length | NA |
| Type | Nucleic Acid |
| Occurence | Synthetic |
| Role of Ligand | it enhances the efficacy of antitumor agents through immune stimulation |
| Name of receptor | Toll-like receptor 9 (TLR9) |
| Type of receptor | Toll-like receptor (TLR) |
| Source | Human patients with advanced non-small cell lung cancer (nSClC) |
| Localization | monocyte/macrophages, plasmacytoid DCs and B-lymphocytes |
| Domain | cell compartment |
| Sequence of Receptor | Q9NR96.fasta |
| Swiss prot ID | Q9NR96 |
| Length Of Receptor | 1032 |
| Function | TLR9 plays a crucial role in breaking tolerance and developing autoimmunity |
| Assay used | NA |
| PMID | 24770667 |
| Year of Publication | 2014 |
| Pubchem assay | Pubchem_assay |